{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:51:12Z","timestamp":1777891872557,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T00:00:00Z","timestamp":1421107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Respir Care"],"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>Aerosolized albuterol delivery is a mainstay treatment for bronchoconstriction; however, almost no data exist that evaluate the clinical outcome of instillation of an endotracheal liquid bolus (ELB) of a bronchodilator directly into the airway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This randomized trial sought to evaluate the efficacy of albuterol lavage via artificial airway with accompanied patient positioning. Subjects receiving mechanical ventilation for acute respiratory failure with clinical manifestations of bronchoconstriction were assigned to initially receive either traditional albuterol via metered-dose inhaler (MDI) or albuterol via ELB lavage with follow-up administration of the other therapy after a 4-h washout period. Clinical data were collected at baseline and at 5 and 30 min post-treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Fourteen subjects (5 males, 9 females; mean age of 57.5 y) were included in this study. In the group receiving initial ELB, peak airway pressure decreased significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .02), and a significant decrease in airway resistance mean scores was seen from baseline to 30 min post-treatment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and from 5 to 30 min post-treatment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .003), with no significant effects seen with follow-up MDI. In the initial MDI treatment group, no significant effect on peak airway pressure or airway resistance was noted. S\n                      <jats:sub>\n                        pO\n                        <jats:sub>2<\/jats:sub>\n                      <\/jats:sub>\n                      increased at 5 min post-treatment with ELB. In contrast, S\n                      <jats:sub>\n                        pO\n                        <jats:sub>2<\/jats:sub>\n                      <\/jats:sub>\n                      decreased 30 min post-treatment with MDI. Mean arterial pressure decreased post-treatment with ELB. The pattern in heart rate change post-treatment with ELB was similar to that post-treatment with MDI, with a significant increase at the 5-min interval from baseline (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01), followed by a significant decrease at the 30-min interval (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). There were no differences in dynamic compliance at each time interval following administration of both the MDI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .92) and ELB conditions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .18).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>ELB albuterol lavage may be a viable option to reverse bronchoconstriction in intubated patients with limited response to traditional aerosolized albuterol via MDI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4187\/respcare.03494","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T02:26:19Z","timestamp":1421202379000},"page":"627-635","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["A Comparison of Metered-Dose Inhaled Albuterol Versus Endotracheal Liquid Bolus Albuterol for the Treatment of Bronchoconstriction"],"prefix":"10.1177","volume":"60","author":[{"given":"Donald A","family":"Johnston","sequence":"first","affiliation":[{"name":"Louisiana State University Health Sciences Center, Shreveport, Louisiana, at the time of this study but is currently affiliated with University Health Shreveport, Shreveport, Louisiana."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim W","family":"Gilmore","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, Shreveport, Louisiana."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P","family":"Gosselin","sequence":"additional","affiliation":[{"name":"Texas A&amp;M Health Science Center, Bryan, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,1,13]]},"reference":[{"key":"e_1_3_2_2_2","volume-title":"Current Asthma Prevalence\u2014United States, 2006\u20132008","author":"Moorman JE","year":"2011","unstructured":"Moorman JE, , Zahran H, , Truman B, , Molla M. (2011) Current Asthma Prevalence\u2014United States, 2006\u20132008. Atlanta: Epidemiology and Analysis Program office."},{"issue":"256","key":"e_1_3_2_3_2","article-title":"Summary health statistics for US adults: National Health Interview Survey, 2011. National Center for Health Statistics","volume":"10","author":"Schiller JS","year":"2012","unstructured":"Schiller JS, , Lucas JW, , Peregoy JA. (2012) Summary health statistics for US adults: National Health Interview Survey, 2011. National Center for Health Statistics. Vital Health Stat, 10(256).","journal-title":"Vital Health Stat"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.014"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.10.024"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.5.1579"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S47679"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.11.015"},{"key":"e_1_3_2_9_2","first-page":"1513","article-title":"Asthma in adults (acute)","volume":"2011","author":"Rodrigo G","year":"2011","unstructured":"Rodrigo G. Asthma in adults (acute). Clin Evid, 2011; 2011:1513.","journal-title":"Clin Evid"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3282f1982d"},{"issue":"2","key":"e_1_3_2_11_2","first-page":"123","article-title":"Biophysics of airflow within the airway: a review","volume":"26","author":"O'Grady K","year":"1997","unstructured":"O'Grady K, , Doyle DJ, , Irish J, , Gullane P. Biophysics of airflow within the airway: a review. J Otolaryngol, 1997; 26(2):123\u2013128.","journal-title":"J Otolaryngol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199603000-00020"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1994.76.1.45"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2008.05.012"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.1416496"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04490611"},{"issue":"8","key":"e_1_3_2_17_2","first-page":"862","article-title":"An evaluation of MDI (metered dose inhaler) spacers and adapters: their effect on the respirable volume of medication","volume":"37","author":"Ebert J","year":"1992","unstructured":"Ebert J, , Adams AB, , Green-Eide B. An evaluation of MDI (metered dose inhaler) spacers and adapters: their effect on the respirable volume of medication. Respir Care, 1992; 37(8):862\u2013868.","journal-title":"Respir Care"},{"issue":"9","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/194336541998043009004","article-title":"A comparison of inline MDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically ventilated lung model","volume":"43","author":"Rau JL","year":"1998","unstructured":"Rau JL, , Dunlevy CL, , Hill RL. A comparison of inline MDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically ventilated lung model. Respir Care, 1998; 43(9):705\u2013712.","journal-title":"Respir Care"},{"key":"e_1_3_2_19_2","volume-title":"Pharmacology for respiratory care practitioners","author":"Cottrel GP","year":"1995","unstructured":"Cottrel GP, , Surkin HB. Pharmacology for respiratory care practitioners. Philadelphia: FA Davis; 1995."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.07.040"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03832.x"},{"key":"e_1_3_2_22_2","first-page":"197","article-title":"Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies","volume":"5","author":"Bateman E","year":"2010","unstructured":"Bateman E, , Singh D, , Smith D, , Disse B, , Towse L, , Massey D, et al. Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis, 2010; 5:197\u2013208.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.3.930"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.6.7767526"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780131703"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.006"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.029"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.6.ats9-00"},{"issue":"2","key":"e_1_3_2_29_2","first-page":"CD002993","article-title":"Cyclosporin as an oral corticosteroid sparing agent in stable asthma","author":"Evans DJ","year":"2001","unstructured":"Evans DJ, , Cullinan P, , Geddes DM. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst Rev, 2001(2):CD002993.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"e_1_3_2_30_2","first-page":"CD003270","article-title":"Azathioprine as an oral corticosteroid sparing agent for asthma","author":"Dean T","year":"2004","unstructured":"Dean T, , Dewey A, , Bara A, , Lasserson TJ, , Walters EH. Azathioprine as an oral corticosteroid sparing agent for asthma. Cochrane Database Syst Rev, 2004(1):CD003270.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"e_1_3_2_31_2","first-page":"CD002985","article-title":"Gold as an oral corticosteroid sparing agent in stable asthma","author":"Evans DJ","year":"2001","unstructured":"Evans DJ, , Cullinan P, , Geddes DM. Gold as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst Rev, 2001(2):CD002985.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"e_1_3_2_32_2","first-page":"CD000391","article-title":"Methotrexate as a steroid sparing agent for asthma in adults","author":"Davies H","year":"2000","unstructured":"Davies H, , Olson L, , Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev, 2000(2):CD000391.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"e_1_3_2_33_2","first-page":"CD003275","article-title":"Chloroquine as a steroid sparing agent for asthma","author":"Dean T","year":"2003","unstructured":"Dean T, , Dewey A, , Bara A, , Lasserson TJ, , Walters EH. Chloroquine as a steroid sparing agent for asthma. Cochrane Database Syst Rev, 2003(4):CD003275.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2.5.617"},{"issue":"3","key":"e_1_3_2_35_2","first-page":"CD009910","article-title":"Bronchial thermoplasty for moderate or severe persistent asthma in adults","author":"Torrego A","year":"2014","unstructured":"Torrego A, , Sol\u00e0 I, , Munoz AM, , Roqu\u00e9 i Figuls M, , Yepes-Nu\u00f1ez JJ, , Alonso-Coello P, , Plaza V. Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database Syst Rev, 2014;(3)CD009910.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_36_2","unstructured":"Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2011. http:\/\/www.ginasthma.org\/. Accessed November 26 2014."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e3181b2e87d"},{"key":"e_1_3_2_38_2","unstructured":"Nephron Pharmaceuticals. Albuterol sulfate inhalation solution; 2007. http:\/\/www.nephronpharm.com\/images\/upload_images\/file\/Albuterol%200_5%25.pdf. Accessed November 26 2014."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.1.335"},{"issue":"12","key":"e_1_3_2_40_2","first-page":"CD010179","article-title":"Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma","author":"Travers AH","year":"2012","unstructured":"Travers AH, , Milan SJ, , Jones AP, , Camargo CAJr, , Rowe BH. Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Database Syst Rev, 2012;(12):CD010179.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2004.07.014"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.08530699"},{"key":"e_1_3_2_43_2","volume-title":"Egan's fundamentals of respiratory care","author":"Kacmarek RM","year":"2013","unstructured":"Kacmarek RM, , Stoller JK, , Heuer AJ. Egan's fundamentals of respiratory care, 10th edition. St Louis: Elsevier Mosby; 2013.","edition":"10"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/002013240004500603"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04490623"},{"issue":"1","key":"e_1_3_2_46_2","first-page":"60","article-title":"The endotracheal use of emergency drugs","volume":"15","author":"Hasegawa EA","year":"1986","unstructured":"Hasegawa EA. The endotracheal use of emergency drugs. Heart Lung, 1986; 15(1):60\u201363.","journal-title":"Heart Lung"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.970988"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1159\/000337354"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3443"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/002013240104600210"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1114\/1.161"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2010.0846"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/002013249904400122"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/002013240204701104"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/002013240004500703"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/62.10.1053"}],"container-title":["Respiratory Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4187\/respcare.03494","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.03494","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.03494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:12:42Z","timestamp":1777615962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4187\/respcare.03494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,13]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.4187\/respcare.03494"],"URL":"https:\/\/doi.org\/10.4187\/respcare.03494","relation":{},"ISSN":["0020-1324"],"issn-type":[{"value":"0020-1324","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,13]]}}}